Published Articles
Informative pieces written by Tunnell Consulting subject matter experts that have been published in leading
industry publications.
-
State of Quality and Compliance in the Biopharmaceutical Industry
Anastasia Lolas
Ian L Uydess Ph.D.
BioPharm International - April 26, 2013 -
Connecting QbD, Knowledge Management and Supplier Quality Management
James P Catania
BioPharm International - November 20, 2012 -
Through the Lens of Lean
James P Catania
Pharmaceutical Manufacturing - October 18, 2012 -
Reduce Analytical Testing and Costs Without Compromising Compliance
Michael Rutledge Ph.D.
Chet Meyers Ph.D.
BioPharm International - July 11, 2012 -
Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships
William Schmidt
Ian L Uydess Ph.D.
BioPharm International - March 19, 2012 -
Putting Risk-Based Decision-Making Where it Belongs
Greg T Plante
BioPharm International - March 19, 2012 -
QbD: Redefining Time to Market
James P Catania
Pharmaceutical Manufacturing - December 07, 2011 -
Developing and Sustaining A Quality Culture
Ian Uydess Ph.D.
Chet Meyers Ph.D.
BioPharm International - November 11, 2011 -
Beyond the Mandates: Finding Business Value in Mass Serialization and Supply Chain Visibility
Carla Reed
Pharmaceutical Manufacturing - July 05, 2011 -
Impact of cGMP on Supply Chain
Carla Reed
BioPharm International - July 01, 2011 -
Quality by Design: The Case for Change (Part 2)
James Catania
BioPharm International - May 30, 2011 -
Supply Chain Transformation: Strategic Necessity for the Life Sciences
Carla Reed
BioPharm International - March 16, 2011 -
Quality by Design: The Case for Change (Part 1)
James Catania
BioPharm International - March 15, 2011 -
Time to Revisit Supplier Quality Management
James R Darnell
BioPharm International - December 02, 2010 -
Implementing Quality by Design: Are You Ready, or Not?
Bill Schmidt
Pharmaceutical Manufacturing - September 15, 2010 -
How to Reduce Unnecessary Compliance Costs
James P Catania
BioPharm International - July 21, 2010 -
Quality by Design and Compliance Readiness: How Will Implementing Quality by Design Strategies Affect Your Compliance Status?
Chester A Meyers Ph.D.
Debra Weigl
BioPharm International - January 15, 2010 -
QbD and GMPs: How the Convergence of Science and Compliance Will Change the Way We Work
Chester A Meyers Ph.D.
Debra Weigl
BioPharm International - November 02, 2009 -
How to Shift from Reactive Compliance to Strategic Quality Management
Michael M Breggar DPM
BioPharm International - July 01, 2009 -
When Less is More: Lean Can Help Reduce Costs and Improve Compliance Simultaneously
Chris S Driscoll
BioPharm International - May 01, 2009 -
Quality by Design: Four Years and Three Myths Later
Ron D Snee Ph.D.
Pharmaceutical Processing - February 01, 2009 -
Executives & Improvement
Ron D Snee Ph.D.
Contract Pharmaceutical - January 29, 2009 -
Serving Two Masters: Reconciling EMEA/GAMP 5 and FDA/cGMP Phase 1
Sandy Weinberg
Siddharth J Advant Ph.D.
BioPharm International - January 01, 2009

